Fox Hill Wealth Management
- SEC CIK
- 0002016110
- Latest filing
- Aug 18, 2026
VRTX holding history
Vertex Pharmaceuticals Inc in every 13F filed by Fox Hill Wealth Management, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings
- Shares (Q2 2026)
- 629
- Value
- $312.4K
- % of portfolio
- 0.1%
- Quarters held
- 11
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 629 | $312.4K | 0.1% | +4+0.6% | Added | Holders |
| Q1 2026 | 625 | $279.1K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 625 | $283.4K | 0.1% | −24−3.7% | Reduced | Holders |
| Q3 2025 | 649 | $254.2K | 0.1% | −34−5.0% | Reduced | Holders |
| Q2 2025 | 683 | $304.1K | 0.2% | +6+0.9% | Added | Holders |
| Q1 2025 | 677 | $328.2K | 0.2% | −1−0.1% | Reduced | Holders |
| Q4 2024 | 678 | $273.0K | 0.2% | −15−2.2% | Reduced | Holders |
| Q3 2024 | 693 | $322.3K | 0.2% | +25+3.7% | Added | Holders |
| Q2 2024 | 668 | $313.1K | 0.2% | −19−2.8% | Reduced | Holders |
| Q1 2024 | 687 | $287.2K | 0.2% | +15+2.2% | Added | Holders |
| Q4 2023 | 672 | $273.4K | 0.2% | – | No prior filing | Holders |